{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:43Z","timestamp":1762876063072,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.htct.2018.10.005","type":"journal-article","created":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T07:56:17Z","timestamp":1550303777000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proposal of treatment algorithm for immune thromocytopenia in adult patients of a hematology service at a referral center in Northeastern Brazil"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-9791","authenticated-orcid":false,"given":"Ros\u00e2ngela de Albuquerque","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentil Claudino de","family":"Galiza Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda da Silva","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Loiola Ponte Albuquerque","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela Sobreira","family":"Kubrusly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie Sobreira","family":"Kubrusly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.htct.2018.10.005_bib0270","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.htct.2018.10.005_bib0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.blre.2017.01.001","article-title":"The role of splenectomy in autoimmune hematological disorders: outdated or still worth considering?","volume":"31","author":"Sys","year":"2017","journal-title":"Blood Rev"},{"issue":"11","key":"10.1016\/j.htct.2018.10.005_bib0280","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"Rodighiero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.htct.2018.10.005_bib0285","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bjh.12260","article-title":"Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy","volume":"161","author":"Kuter","year":"2013","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.htct.2018.10.005_bib0290","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","article-title":"Morbidity and mortality in adults with idiopathic thrombocytopenic purpura","volume":"97","author":"Portielje","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.htct.2018.10.005_bib0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database immune thrombocytopenic","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2018.10.005_bib0300","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjh.12869","article-title":"Twenty-year mortality of adult patients with primary immunethrombocytopenia: a Danish population-based cohort study","volume":"166","author":"Frederiksen","year":"2014","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.htct.2018.10.005_bib0305","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/ajh.23299","article-title":"Platelet count or bleeding as the outcome in ITP trials?","volume":"87","author":"Arnold","year":"2012","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.htct.2018.10.005_bib0310","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V77.1.31.31","article-title":"High risk of severe bleeding in aged patients with chronic idiopathicthrombocytopenic purpura","volume":"77","author":"Cortelazzo","year":"1991","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.htct.2018.10.005_bib0320","first-page":"87","article-title":"Idiopathic thrombocytopenic purpura: diagnosis and management","volume":"316","author":"George","year":"1998","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenia purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2018.10.005_bib0330","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.htct.2018.10.005_bib0335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.htct.2018.10.005_bib0340","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.htct.2018.10.005_bib0345","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.htct.2018.10.005_bib0350","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/0003-4819-104-6-808","article-title":"Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion","volume":"104","author":"Baumann","year":"1986","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.htct.2018.10.005_bib0355","doi-asserted-by":"crossref","first-page":"E330","DOI":"10.1002\/ajh.24409","article-title":"The \u201cplatelet boilermaker\u201d: a treatment protocol to rapidly increase platelets in patients with immune-mediated thrombocytopenia","volume":"91","author":"Olson","year":"2016","journal-title":"Am J Hematol"},{"issue":"15","key":"10.1016\/j.htct.2018.10.005_bib0360","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM198904133201505","article-title":"Mechanisms of response to treatment in autoimmune thrombocytopenic purpura","volume":"320","author":"Gernsheimer","year":"1989","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.htct.2018.10.005_bib0365","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0037-1963(00)90104-5","article-title":"Fc receptor blockade and immune thrombocytopenic purpura","volume":"37","author":"Bussel","year":"2000","journal-title":"Sem Hematolol"},{"issue":"1105","key":"10.1016\/j.htct.2018.10.005_bib0370","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/postgradmedj-2017-135036","article-title":"Primary immune thrombocytopenia in adults: clinical practice versus management guidelines","volume":"93","author":"Ng","year":"2017","journal-title":"Postgrad Med J"},{"issue":"24","key":"10.1016\/j.htct.2018.10.005_bib0375","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/bloodadvances.2017009860","article-title":"Management of newly diagnosed immune thrombocytopenia: can we change outcomes?","volume":"1","author":"Neunert","year":"2017","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.htct.2018.10.005_bib0380","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.htct.2018.10.005_bib0385","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood-2011-12-309153","article-title":"treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment","volume":"120","author":"Ghanima","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.htct.2018.10.005_bib0390","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ajh.21501","article-title":"Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review","volume":"84","author":"Mikhael","year":"2009","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0395","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archinte.1989.00390010179028","article-title":"Emergency splenectomy in adult idiopathic thrombocytopenic purpura a report of seven cases","volume":"149","author":"Wanachiwanawin","year":"1989","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.htct.2018.10.005_bib0400","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1076029614526639","article-title":"Immune thrombocytopenia: recent progress in pathophysiology and treatment","volume":"21","author":"Abadi Uri","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"10.1016\/j.htct.2018.10.005_bib0405","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3324\/haematol.2012.075648","article-title":"Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years","volume":"98","author":"Vianelli","year":"2013","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.htct.2018.10.005_bib0410","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.htct.2018.10.005_bib0415","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MAJ.0b013e31827f4dd1","article-title":"Management of primary immune thrombocytopenia, 2012: a survey of Oklahoma hematologists\u2013oncologists","volume":"347","author":"Lu","year":"2014","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0420","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1053\/j.seminhematol.2013.03.014","article-title":"B-cell depletion in immune thrombocytopenia","volume":"50","author":"Godeau","year":"2013","journal-title":"Sem Hematol"},{"issue":"25","key":"10.1016\/j.htct.2018.10.005_bib0425","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-11-393975","article-title":"Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia","volume":"119","author":"Patel","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2018.10.005_bib0430","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","article-title":"Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura","volume":"110","author":"Stasi","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2018.10.005_bib0435","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab","volume":"112","author":"Stasi","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0440","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12185-010-0753-z","article-title":"Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia","volume":"93","author":"Li","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.htct.2018.10.005_bib0445","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMct1014202","article-title":"Thrombopoietin-receptor agonists for primary immune thrombocytopenia","volume":"365","author":"Imbach","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0450","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-013-1370-4","article-title":"Pathophysiology and management of primary immune thrombocytopenia","volume":"98","author":"Kashiwagi","year":"2013","journal-title":"Int J Hematol"},{"issue":"11","key":"10.1016\/j.htct.2018.10.005_bib0455","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1111\/trf.12139","article-title":"Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists","volume":"53","author":"Ghadaki","year":"2013","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.htct.2018.10.005_bib0460","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bjh.13827","article-title":"Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study","volume":"172","author":"Newland","year":"2016","journal-title":"Br J Haematol"},{"year":"2013","series-title":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria N\u00b0 1.316, de 22 de Novembro de 2013. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da P\u00farpura Trombocitop\u00eanica Idiop\u00e1tica. Bras\u00edlia, DF","author":"Minist\u00e9rio da Sa\u00fade (MS\/BR)","key":"10.1016\/j.htct.2018.10.005_bib0465"},{"issue":"23","key":"10.1016\/j.htct.2018.10.005_bib0470","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2017-04-748707","article-title":"Safety and efficacy of long-term treatment of chronic\/persistent ITP with eltrombopag: final results of the EXTEND study","volume":"130","author":"Wong","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.htct.2018.10.005_bib0475","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.revmed.2015.08.007","article-title":"Is there still a place for old therapies in the management of immune thrombocytopenia","volume":"37","author":"Audia","year":"2016","journal-title":"La Rev M\u00e9d Intern"},{"issue":"2","key":"10.1016\/j.htct.2018.10.005_bib0480","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/09537104.2014.886677","article-title":"Dapsone for immune thrombocytopenic purpura in children and adults","volume":"26","author":"Patel","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.htct.2018.10.005_bib0485","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ajh.22266","article-title":"Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab","author":"Zaja","year":"2012","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.htct.2018.10.005_bib0490","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1182\/blood-2016-03-603365","article-title":"How I treat refractory of immune thrombocytopenia","volume":"128","author":"Cuker","year":"2016","journal-title":"Blood"},{"year":"2014","series-title":"Protocolos de tratamento: hematologia e hemoterapia","author":"Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti","key":"10.1016\/j.htct.2018.10.005_bib0495"},{"issue":"2","key":"10.1016\/j.htct.2018.10.005_bib0500","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.1990.tb02569.x","article-title":"Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases","volume":"74","author":"Quiquandon","year":"1990","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0505","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjh.14515","article-title":"State of the art \u2013 how I manage immune thrombocytopenia","volume":"177","author":"Cooper","year":"2017","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.htct.2018.10.005_bib0510","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1182\/blood-2016-03-704734","article-title":"Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia","volume":"128","author":"Mah\u00e9vas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.htct.2018.10.005_bib0515","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.htct.2018.10.005_bib0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bjhh.2017.09.005","article-title":"Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil","volume":"40","author":"Barbosa","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"issue":"12","key":"10.1016\/j.htct.2018.10.005_bib0525","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1182\/blood-2006-12-063222","article-title":"Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles","volume":"110","author":"Emilia","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2018.10.005_bib0530","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00277-008-0667-5","article-title":"Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study","volume":"88","author":"Tsumoto","year":"2009","journal-title":"Ann Hematol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137919300173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137919300173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:31:36Z","timestamp":1762867896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137919300173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2531137919300173"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2018.10.005","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposal of treatment algorithm for immune thromocytopenia in adult patients of a hematology service at a referral center in Northeastern Brazil","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}